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Abstract
A composite membrane of the polymer, chitosan, and the silver-exchanged mineral phase, tobermorite, was prepared 
by solvent casting and characterised by scanning electron microscopy and Fourier transform infrared spectroscopy. 
The in vitro bioactivity, cytocompatibility and antimicrobial activity of the composite were evaluated with respect to 
its potential application as a guided tissue regeneration (GTR) membrane. The in vitro bioactivity was veriied by the 
formation of hydroxyapatite on the surface of the membrane in simulated body luid and its cytocompatibility was 
established using MG63 human osteosarcoma cells. The presence of silver ions conferred signiicant antimicrobial 
activity against S. aureus, P. aeruginosa and E. coli. The indings of this investigation have indicated that the chitosan-
silver-tobermorite composite is a prospective candidate for GTR applications.
Keywords: chitosan, tobermorite, silver, bioactive, antimicrobial, guided tissue regeneration, periodontal repair.
1. Introduction
Periodontitis - inflammation and progressive destruction of 
the tooth attachment apparatus - is one of the most widespread 
infectious diseases in the world[1]. This disease is initiated 
by the accumulation of bacterial plaque biofilms causing 
gingivitis, which, if left untreated, leads to the detachment 
of the epithelial tissue, disconnection of the periodontal 
ligament (PDL) and the loss of cementum and alveolar 
bone[1-3]. Traditional treatment of this condition involves the 
removal of plaque and calculus from the root surface without 
an attempt to restore the surrounding tissues. The rapidly 
growing epithelial cells subsequently propagate alongside the 
tooth root and prevent the re-establishment of the PDL and 
alveolar bone. Thus the treated periodontal tissues possess 
a long junctional epithelium and are vulnerable to further 
bacterial infection and recurrent episodes of periodontitis.
The use of biocompatible membranes for the guided 
tissue regeneration (GTR) of compromised periodontal 
structures is an increasingly popular option for the treatment 
of periodontitis[1-4]. The GTR approach involves the 
placement of a membrane to exclude the fast-growing soft 
tissues from the exposed root surface in order to enable the 
more slow-growing PDL and hard tissues to regenerate[1-4]. 
These GTR barriers can be fabricated from either non-resorbable 
materials (e.g. PTFE) which require surgical removal after 
service, or resorbable materials (e.g. poly(urethane)) which 
will biodegrade in situ. In both cases, the principal cause of 
failure of GTR membranes is bacterial biofilm formation 
leading to infection; hence, improvements in the design of 
GTR membranes to incorporate antimicrobial components 
are now required[1].
Chitosan is the partially N-deacetylated derivative 
of chitin, a naturally abundant structural polysaccharide 
obtained from the shells of crustaceans[5-7]. It is non-toxic, 
biodegradable, biocompatible, bioactive, non-antigenic, 
antimicrobial and finds current biomedical application in 
wound dressings and medical textiles[5-9]. It is a basic linear 
co-polymer of glucosamine and N-acetylglucosamine whose 
structure resembles that of bone extracellular matrix (ECM)
[10,11]. In comparison with traditional treatment, the application 
of bioresorbable chitosan-based GTR membranes has been 
shown to successfully promote the regeneration of the tooth 
attachment tissues in canine models[12-14].
Despite its many advantages, chitosan in GTR applications 
is not sufficiently bioactive to stimulate optimum bone tissue 
regeneration. It is also prone to bacterial biofilm formation. 
Previous studies have indicated that blending chitosan with 
finely divided bioactive and antibacterial phases, such as 
bioactive glasses, calcium phosphate minerals and silver 
nanoparticles can enhance bone tissue regeneration and 
reduce bacterial biofilm formation[11,15,16].
Tobermorite, Ca
5
Si
6
O
16
(OH)
2
.4H
2
O, is a bioactive 
calcium silicate phase that can be ion-exchanged with 
antibacterial silver ions[17,18]. The layered structure of 
tobermorite resembles the calcium silicate hydrate gel phases 
of the endodontic cements, MTA and Biodentine, which are 
reported to stimulate the regeneration of cementum and 
bones tissues[19-21]. A recent in vitro study has demonstrated 
that the incorporation of synthetic tobermorite into chitosan 
films enhances both bioactivity and biocompatibility[22].
In this work, a candidate composite GTR membrane of 
chitosan and silver-exchanged tobermorite has been prepared 
by solvent-casting and characterised by scanning electron 
microscopy (SEM) and Fourier transform infrared spectroscopy 
(FTIR). The bioactivity of the composite membrane was 
evaluated in vitro and its biocompatibility was assessed 
using human MG63 osteosarcoma cells. An inhibition zone 
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 assay was used to determine the antimicrobial activity of the 
membrane against Staphylococcus aureus, Pseudomonas 
aeruginosa and Escherichia coli.
2. Materials and Methods
2.1 Preparation and characterisation
Chitosan (50-190 kDa molecular weight, 75-85% 
deacetylated) and all other reagents were purchased from 
Sigma-Aldrich, UK, and used without further modification. 
Triplicate samples of silver-exchanged tobermorite were 
prepared characterised by powder X-ray diffraction (XRD) 
analysis and X-ray fluorescence spectroscopy (XRF), as 
described in reference[18]. The Bragg peaks of the silver-
exchanged tobermorite were identified and indexed 
using JCPDS file 45-1480. The formulae of the original 
tobermorite and Ag-tobermorite used in this study were 
Ca
4.55
Na
0.44
Si
6.00
O
16.77
.6.4H
2
O and Ca
4.06
Na
0.04
Ag
0.92
Si
6.00 
O
16.54
.11.9H
2
O, respectively.
Chitosan-silver-tobermorite composite membranes 
(CTAg) were prepared at a chitosan:Ag-tobermorite mass 
ratio of 10:7 by solvent casting. 2% (w/v) solutions of 
chitosan were prepared in triplicate by dissolving 0.6 g 
of the polymer in 30 cm3 of 2% (v/v) acetic acid solution. 
0.42 g of Ag-tobermorite were then added and the mixtures 
were stirred for 5 hours, cast onto polycarbonate plates and 
dried in air at 60 °C to constant mass to produce the CTAg 
membranes. Control membranes (labelled CT) for the 
antimicrobial inhibition zone assay were prepared similarly 
with the original tobermorite samples.
The CTAg membranes were characterised by FTIR using 
a Perkin Elmer Paragon spectrometer and by SEM using 
uncoated samples attached to carbon tabs on an Hitachi 
SU8030 scanning electron microscope. Secondary electron 
images were obtained at an accelerating voltage of 1 kV.
2.2 In vitro bioactivity analysis of CTAg membrane
Simulated body fluid (SBF) was prepared according to 
the method described by Kokubo and Takadama[23]. 16 cm3 
sections of CTAg membrane were placed in 20 cm3 of SBF 
solution in sealed polypropylene containers at 37 °C for 
periods of 3, 7 and 14 days. The pH of the SBF solution 
was measured using a Jenway 3150 pH meter and the 
concentrations of calcium, phosphorus and silicon were 
monitored by inductively coupled plasma analysis using 
a Perkin Elmer Optima 4300 DV spectrophotometer and 
multi-element standards. The recovered CTAg membranes 
were rinsed with deionised water, dried in air at 37 °C for 
24 h and analysed by FTIR. Each analysis was carried out 
in triplicate.
2.3 Kirby-Bauer inhibition zone assay of CTAg and CT 
membranes
The antimicrobial properties of the CTAg and CT 
membranes were assessed using the Kirby-Bauer inhibition 
zone method against Staphylococcus aureus NCIMB 9518, 
Escherichia coli NCIMB 9132 and Pseudomonas aeruginosa 
NCIMB 8628. Overnight cultures of each bacterium were 
spread on nutrient agar plates. Individual 8 mm discs of the 
CTAg and CT membranes were placed in the centre of each 
spread plate. Each assay was conducted in quadruplicate. 
The plates were examined for clear zones after incubation 
at 37 °C for 24 hours. The final population densities of the 
plates spread with S. aureus, E. coli and P. aeruginosa were 
approximately 1.0 x 109, 5.9 x 108, and 5.9 x 109 colony 
forming units per plate.
2.4 In vitro biocompatibility of CTAg membrane
The in vitro biocompatibility of the CTAg membrane was 
evaluated using MG63 human osteosarcoma cells (ECACC 
code: 86051601) as described in reference [22]. In triplicate, 
either 0, 1 or 4 CTAg membrane strips (1 mm x 4 mm) 
were incubated with the MG63 cells for 24 hours and cell 
viability was established using an MTT (3-(4,5-Dimethyl-2-
thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide) assay[22]. 
Data were subjected to a one-tailed t-test at (n  2) degrees 
of freedom and P = 0.05.
3. Results and Discussion
3.1 Materials characterisation
The powder XRD pattern of Ag-tobermorite is shown in 
Figure 1a and closely resembles those of other tobermorites 
reported in the literature[18,24]. Minor traces of calcite, CaCO
3
, 
(denoted by asterisks) are also present and commonly arise 
from atmospheric carbonation during the hydrothermal 
preparation of tobermorites. These data confirm that silver 
ions were exchanged for calcium and sodium ions within the 
tobermorite phase without any notable structural disruption 
of the lattice and that no silver-bearing precipitates were 
formed.
Figure 1. (a) XRD pattern of silver-exchanged tobermorite, 
(b) SEM image of CTAg composite membrane.
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An SEM micrograph of the CTAg composite is presented 
in Figure 1b and shows that the membranes topography is 
highly textured on a sub-micron scale and that the surface 
is characterised by fibrous tobermorite particles dispersed 
throughout a network of felted chitosan strands.
The FTIR spectrum of Ag-tobermorite is presented in 
Figure 2a. The bands at ca. 960 cm-1 and 675 cm-1 arise 
from various Si-O stretching modes and Si-O-Si bending 
vibrations, respectively[16]. O-H vibrations of silanol bonds 
and interlayer water molecules give rise to the broad bands 
at 1630 and 3450 cm1.
The FTIR spectrum of chitosan is shown in Figure 2b. 
The broad signal at ~3460 cm1 is attributed to N-H and O-H 
stretching modes which overlap in this region; and the bands 
at 1650 and 1570 cm1 arise from amide I C=O stretching 
and amide II N-H bending vibrations, respectively[25]. C-H 
stretching vibrations occur at 2960-2965 cm1 and C-H 
bending modes give rise to the bands at 1420-1430 cm1 
and 1365 cm1. Various C-O-C stretching frequencies occur 
in the range 1160  1060 cm-1 and the band at 1295 cm1 is 
attributed to C-O-H stretching vibrations. The FTIR spectrum 
of the solvent-cast CTAg composite membrane, shown in 
Figure 2c, is essentially the sum of the individual spectra 
of Ag-tobermorite and chitosan with no significant shifts 
in the characteristic bands of either material. However, 
the bands at 1365, 1295 and 1160 cm-1 (which arise from 
aliphatic C-H, C-O-H and C-O-C groups, respectively) 
are less distinct and appear as poorly resolved shoulders in 
the spectrum of the composite owing to the overlap of the 
Si-O band of the tobermorite. The diminished intensity of 
the C-O-H band could also indicate an interaction between 
this group and the tobermorite lattice.
3.2 In vitro bioactivity of the CTAg membrane
The in vitro formation of a layer of substituted 
hydroxyapatite, Ca
10
(PO
4
)
6
(OH)
2
, (HA) on the surface of 
a material placed in SBF solution provides an indication of 
its bioactivity (i.e. the ability of the material to bond with 
living bone tissue)[23].
The formation of an HA layer on the surface of the CTAg 
membrane was monitored by FTIR spectroscopy and ICP 
analysis. The FTIR spectra of CTAg following exposure 
to SBF for 3, 7 and 14 days are shown in Figures 2(d), (e) 
and (f), respectively, and the corresponding concentrations 
of calcium, phosphorus and silicon species in the solution 
are presented in Figure 3.
Characteristic phosphate P-O bending modes of HA are 
noted at 570-610 cm1 in the FTIR spectrum of the CTAg 
membrane after 3 days residence in SBF (Figure 2d). 
The additional broadening of the combination band at ca. 
1075 cm1 arises from the contribution of P-O stretching 
modes in the 1000-1220 cm1 range and is further evidence 
for the formation of HA[20]. The corresponding removal 
of phosphate ions and release of silicate and calcium ions 
are plotted in Figure 3. These data indicate that the SBF 
solution is essentially depleted of phosphate ions within 
14 days as the HA precipitation process nears completion. 
The silicate ion concentration of SBF rises from zero to 
66 ppm within the first 3 days which corresponds with the 
dissolution of approximately 43% of the Ag-tobermorite 
lattice. The rate of dissolution of the Ag-tobermorite lattice 
then slows significantly, which is likely to be attributed to 
the solubility limit of silicate species in this closed system. 
The degradation of the Ag-tobermorite matrix also causes a 
steady increase in the supernatant concentration of calcium 
ions and a comparatively slow release of silver ions. Silver is 
only detected in solution at 7 and 14 days at concentrations 
of 0.5 and 4.6 ppm, respectively, which correspond to the 
respective release of 0.6 and 1.1% of the total mass of 
silver present in the membrane. The delayed release of 
silver ions into the SBF solution during the degradation 
of the Ag-tobermorite lattice may arise from ion exchange 
interactions with the functional groups of chitosan.
In spite of the steady release of calcium ions throughout 
the investigation, the pH of the SBF solution varied little 
about the original value of 7.45 (Figure 3). This indicates 
that the alkaline dissolution products of the Ag-tobermorite 
Figure 2. FTIR spectra of (a) Ag-tobermorite, (b) chitosan, 
(c) CTAg membrane and CTAg membrane after immersion in SBF 
for (d) 3 days, (e) 7 days and (f) 14 days.
Figure 3. Concentrations of P, Ca, Si and Ag in SBF and 
corresponding pH as functions of residence time.
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lattice are buffered by the acidic degradation products of 
the chitosan.
3.3 Antibacterial properties of CTAg and CT membranes
The results of the antibacterial inhibition zone assays 
using S. aureus, P. aeruginosa and E. coli are listed in Table 1. 
Distinct clear zones were noted around the silver-bearing 
CTAg composite membranes in contact with all three 
microorganisms and in each case the bacteria were observed 
to readily colonise the surfaces of the control CT discs.
The microbiota of the dental biofilm in periodontitis is 
highly complex. In addition to the characteristic anaerobic 
Gram-negative oral microorganisms, the non-oral pathogenic 
bacteria S. aureus, P. aeruginosa and E. coli are commonly 
detected within the subgingival biofilm of patients with 
chronic and aggressive periodontitis[26,27]. These bacteria 
are highly prevalent in bone and dental implant-centred 
infections and are among the principal pathogens associated 
with osteomyelitis[28,29].
The eradication of S. aureus, P. aeruginosa and E. coli 
in the presence of implanted biomaterials is particularly 
challenging owing to their biofilm formation and superior 
antimicrobial resistance[29]. Once bacterial adhesion has 
occurred on a biomaterial implant surface, the microorganisms 
secrete an exopolysaccharide layer that protects them from 
the hosts immune response and from subsequent antibiotic 
therapy. The host tissue cells are then unlikely to be able to 
displace the persistent biofilm and the implant will require 
surgical revision.
One strategy to promote host tissue integration over 
bacterial biofilm formation on implantable biomaterials 
is the incorporation of antibiotic components[29]. In this 
respect, silver salts, nanoparticles and complexes have 
been incorporated into a range of wound-dressings and 
implantable biomedical devices to exploit the broad-spectrum 
antimicrobial properties of this metal[18].
This research has indicated that the silver-free CT 
membranes readily supported colonies of S. aureus, 
P. aeruginosa and E. coli at concentrations of 1.0 x 109, 
5.9 x 109, and 5.9 x 108 colony forming units per plate, 
respectively. Conversely, marked inhibitory effects were noted 
for each microorganism in the presence of the silver-bearing 
CTAg membranes. Similar prophylaxis against microbial 
colonisation by S. aureus and E. coli has also been reported 
for composites comprising chitosan and a commercial 
silver-exchanged zeolite (Ag-Ion) which are intended as 
antimicrobial food packaging materials[30].
3.4 In vitro biocompatibility of CTAg membrane
It is essential that a bioactive GTR membrane is 
biocompatible with bone tissue. In this respect, human 
osteosarcoma cells provide a model for the initial in vitro 
cytotoxicity appraisal of candidate biomaterials for bone 
tissue regeneration. The indirect cytotoxicity of the CTAg 
membrane towards MG63 human osteosarcoma cells was 
evaluated using an MTT assay. This method is derived from 
the ability of viable cells to reduce the tetrazolium salt of 
MTT into formazan which is then monitored colorimetrically. 
The cell viability data for cultures in contact with increasing 
quantities of CTAg membrane are compared with those of 
the control (which consisted of cells and media only) in 
Figure 4. These data indicate that there is no significant loss 
of cell viability for the cultures in contact with 1 and 4 CTAg 
membrane strips compared with the control (P = 0.05).
In a similar study, the in vitro viability of human 
osteosarcoma cells was maintained when exposed to a 
porous chitosan-hydroxyapatite tissue scaffold embedded 
with silver nanoparticles[16]. Conversely, marked cytotoxic 
effects on MG63 osteosarcoma cells were observed for 
a composite coating comprising chitosan, Bioglass and 
silver nanoparticles[31]. Other research has indicated that 
the dosage and chemical form in which silver is presented 
(i.e. as ions, complexes, elemental powder or nanoparticles) 
impacts upon its biocompatibility with respect to mammalian 
cells[32]. In this case, the dosage and form of silver within the 
CTAg composite membrane is able to confer antimicrobial 
activity without compromising in vitro biocompatibility 
with respect to osteosarcoma cells.
3.5 CTAg as a GTR membrane
Extensive clinical research has indicated that the GTR 
membrane-assisted regeneration of damaged periodontal 
tissues is favoured over traditional treatment approaches for 
periodontitis. The principal functions of the GTR membrane 
are to maintain an appropriate volume into which the 
compromised PDL and alveolar bone tissues can repopulate 
and to exclude invasion from the more fast-growing gingival 
and epithelial tissues. A further, desirable property of the 
GTR membrane would be an ability to stimulate and enhance 
the regeneration of the damaged tissues; and an additional 
asset would be the ability of the material to control bacterial 
activity at the wound site. This latter property is especially 
significant, as the damaged periodontal tissue is in contact 
with the external environment of the oral cavity and is at a 
high risk of infection during the healing process.
Table 1. Inhibition zone data for CTAg and CT membranes.
Bacterium CTAg CT control
S. aureus
Zone of inhibition (mm) 0.81 ± 0.13 0
P. aeruginosa
Zone of inhibition (mm) 1.44 ± 0.12 0
E. coli
Zone of inhibition (mm) 1.07 ± 0.13 0
Figure 4. Viability of MG63 human osteosarcoma cells in contact 
with CTAg composite membrane strips.
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The principal disadvantages of chitosan in GTR 
applications are that its bioactivity and antimicrobial 
properties are insufficient and that its acidic dissolution 
products stimulate inflammatory reactions that inhibit 
healing[1,25]. This study confirms that the CTAg membrane 
exhibits in vitro bioactivity and that the tobermorite lattice 
degrades on contact with SBF to release calcium, silicate, 
silver and hydroxide ions. The basic calcium and hydroxide 
ions buffer the acidic breakdown products of the chitosan 
and reduce deviations from the normal physiological pH of 
~7.45. Also, the dissolved silicate and calcium ions are both 
potent chemical signals for osteoblast activity and directed 
bone cell growth[1,33,34].
In addition to the chemical environment, local topography 
also regulates the adhesion, expression and growth of 
osteocytes. Mineralised alveolar bone, cementum and bone 
ECM possess micron and sub-micron scale textures that 
favour the attachment and proliferation of bone tissue cells. 
In this respect, the sub-micron scale roughness of the CTAg 
membrane and the release of calcium and silicate ions from 
the tobermorite lattice are all anticipated to contribute to 
its therapeutic potential with respect to the regeneration of 
compromised alveolar bone.
The incorporation of silver cations in the composite 
membrane contributes significantly to its antimicrobial 
activity against both Gram-positive (S. aureus) and Gram-
negative (P. aeruginosa and E. coli) bacteria with no observed 
compromise in cytocompatibility. The very slow release 
of silver ions from the CTAg membrane is also considered 
advantageous, as this is likely to provide sustained microbial 
resistance to bacterial biofilm formation.
4. Conclusions
A textured polymer-mineral composite membrane has 
been prepared by solvent casting a mixture of chitosan 
and silver-bearing tobermorite. The composite membrane 
exhibited in vitro bioactivity in simulated body fluid and 
its cytocompatibility was confirmed using MG63 human 
osteosarcoma cells via MTT assay. The acidic degradation 
products of the chitosan polymer were buffered by the 
alkaline dissolution products of the tobermorite lattice and 
the slow release of sliver ions significantly enhanced the 
antimicrobial activity of the membrane against S. aureus, 
P. aeruginosa and E. coli. The results of this investigation 
have indicated that the chitosan-silver-tobermorite composite 
is a prospective candidate for GTR applications.
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